Molecular Biology of Prostate Cancer

2020

Sipeky, C, Talala, KM, Tammela, TLJ, Taari, K, Auvinen, A, Schleutker, J et al.. Prostate cancer risk prediction using a polygenic risk score. Sci Rep. 2020;10 (1):17075. doi: 10.1038/s41598-020-74172-z. PubMed PMID:33051487 PubMed Central PMC7553910.
Pakarainen, T, Nevalainen, J, Talala, K, Taari, K, Raitanen, J, Kujala, P et al.. Number of screening rounds attended and incidence of high-risk prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC). Cancer. 2021;127 (2):188-192. doi: 10.1002/cncr.33254. PubMed PMID:33048394 .
Hietikko, R, Kilpeläinen, TP, Kenttämies, A, Ronkainen, J, Ijäs, K, Lind, K et al.. Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study. Cancer Imaging. 2020;20 (1):72. doi: 10.1186/s40644-020-00351-w. PubMed PMID:33036660 PubMed Central PMC7547469.
Pöyhönen, A, Åkerla, J, Koskimäki, J, Tammela, TLJ, Auvinen, A. Seasonal changes in occurrence and severity of lower urinary tract symptoms-Tampere Aging Male Urologic Study (TAMUS). Low Urin Tract Symptoms. 2021;13 (2):216-223. doi: 10.1111/luts.12353. PubMed PMID:33034153 .
Kujala, MM, Tammela, TL, Pöyhönen, A, Forsell, T, Pasanen, S, Paananen, I et al.. Prevalence of autoimmune disorders among bladder pain syndrome patients’ relatives. Scand J Urol. 2021;55 (1):72-77. doi: 10.1080/21681805.2020.1821766. PubMed PMID:32964777 .
Fizazi, K, Shore, N, Tammela, TL, Ulys, A, Vjaters, E, Polyakov, S et al.. Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide. N Engl J Med. 2020;383 (11):1040-1049. doi: 10.1056/NEJMoa2001342. PubMed PMID:32905676 .
Siltari, A, Murtola, TJ, Talala, K, Taari, K, Tammela, TLJ, Auvinen, A et al.. Antihypertensive drug use and prostate cancer-specific mortality in Finnish men. PLoS One. 2020;15 (6):e0234269. doi: 10.1371/journal.pone.0234269. PubMed PMID:32598349 PubMed Central PMC7323967.
Huynh-Le, MP, Fan, CC, Karunamuni, R, Walsh, EI, Turner, EL, Lane, JA et al.. A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data. Cancer Epidemiol Biomarkers Prev. 2020;29 (9):1731-1738. doi: 10.1158/1055-9965.EPI-19-1527. PubMed PMID:32581112 PubMed Central PMC7483627.
Kohvakka, A, Sattari, M, Shcherban, A, Annala, M, Urbanucci, A, Kesseli, J et al.. AR and ERG drive the expression of prostate cancer specific long noncoding RNAs. Oncogene. 2020;39 (30):5241-5251. doi: 10.1038/s41388-020-1365-6. PubMed PMID:32555329 .
Karunamuni, RA, Huynh-Le, MP, Fan, CC, Eeles, RA, Easton, DF, Kote-Jarai, Z et al.. The effect of sample size on polygenic hazard models for prostate cancer. Eur J Hum Genet. 2020;28 (10):1467-1475. doi: 10.1038/s41431-020-0664-2. PubMed PMID:32514134 PubMed Central PMC7608255.
Talala, K, Heinävaara, S, Taari, K, Tammela, TLJ, Kujala, P, Stenman, UH et al.. Long-term health-related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer. Cancer Med. 2020;9 (15):5643-5654. doi: 10.1002/cam4.3181. PubMed PMID:32500650 PubMed Central PMC7402814.
Kilpeläinen, TP, Talala, K, Taari, K, Raitanen, J, Kujala, P, Pylväläinen, J et al.. Patients’ education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer. Eur J Cancer. 2020;130 :204-210. doi: 10.1016/j.ejca.2020.02.045. PubMed PMID:32229417 .
Rantapero, T, Wahlfors, T, Kähler, A, Hultman, C, Lindberg, J, Tammela, TL et al.. Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer. Genes (Basel). 2020;11 (3):. doi: 10.3390/genes11030314. PubMed PMID:32183364 PubMed Central PMC7140841.

Search PubMed

2019

2018

2017

2016

2015